sask.-vaccine-developer-locks-in-canadian-manufacturers-for-human-clinical-trials

Sask. vaccine developer locks in Canadian manufacturers for human clinical trials

VIDO-InterVac researchers

The University of Saskatchewan has contracted two Canadian pharmaceutical companies to manufacture ingredients for its COVID-19 vaccine for the first stages of human clinical trials. 

0 0 vote
Article Rating
guest
0 Comments
Inline Feedbacks
View all comments